Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Rivastigmine MeSH Descriptor Data 2026


MeSH Heading
Rivastigmine
Tree Number(s)
D02.241.081.251.583.899
Unique ID
D000068836
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D000068836
Scope Note
A carbamate-derived reversible CHOLINESTERASE INHIBITOR that is selective for the CENTRAL NERVOUS SYSTEM and is used for the treatment of DEMENTIA in ALZHEIMER DISEASE and PARKINSON DISEASE.
Entry Term(s)
(S)-N-Ethyl-3-((1-dimethyl-amino)ethyl)-N-methylphenylcarbamate
ENA 713
ENA-713
Exelon
Rivastigmine Hydrogen Tartrate
RivastigmineTartrate
SDZ ENA 713
Pharm Action
Cholinesterase Inhibitors
Neuroprotective Agents
Registry Numbers
PKI06M3IW0
0
9IY2357JPE
Related Numbers
123441-03-2
129101-54-8
9IY2357JPE
CAS Type 1 Name
Carbamic acid, ethylmethyl-, 3-(1-(dimethylamino)ethyl)phenyl ester, (S)-, (R-(R*,R*))-2,3-dihydroxybutanedioate (1:1)
Public MeSH Note
2016; RIVASTIGMINE was indexed under PHENYLCARBAMATES 2004-2015; and under CARBAMATES 1992-2004
History Note
2016 (1992)
Date Introduced
2016/01/01
Last Updated
2016/05/20
Rivastigmine Preferred
Exelon Narrower
RivastigmineTartrate Narrower
ENA 713 Related
page delivered in 0.125s